how long will semaglutide shortage last ends as FDA sets deadline for compounders Novo Nordisk's semaglutide shortage officially

Mergers and acquisitions: some key deals in 2025 Although there were no mega deals in the bio/pharmaceutical in terms of the prescription drug market, there were some key mergers and acquisitions (M&A) as the top companies built their pipelines and portfolios through bolt-on acquisitions

Augmented hypoxic cerebral vasodilation in men during 5 days at 3,810 m altitude

A 2025 randomized pragmatic trial found that semaglutide resulted in a 15% greater reduction in HbA1c levels than common hormone treatments, suggesting a clinically meaningful advantage in glycemic lowering versus hormone-based comparators in that study population

Loss of immune privilege

A single, slightly lower dose is unlikely to have a noticeable impact on your overall metabolic health

These medications have been shown to cross the placenta and reach the fetal blood, but the drug is found in much lower levels in the fetus than in the mother